RO7234292 (ISIS 443139)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7234292 (ISIS 443139), covering 2021-01-19 to 2021-01-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139) [Phase 2]